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E-mail address: myriam.baes@pharm.kuleuven.beaP2-Cremice have amply been used to generate conditional adipose selective inactivation of impor-
tant signaling molecules. We show that the efﬁciency of Cre mediated recombination in adipocytes
and adipose selectivity is not always guaranteed. In particular, Cre activity was found in ganglia of
the peripheral nervous system (PNS), in adrenal medulla and in neurons throughout the central ner-
vous system (CNS). Because these tissues have an important impact on adipose tissue, care should be
taken when using aP2-Cre mice to deﬁne the role of the targeted genes in adipose tissue function.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction ported to exhibit variable and mosaic Cre activity in white (WAT)Mouse knockout studies have importantly contributed to novel
insights in the role of signaling molecules that impact on adipocyte
differentiation and function. In some instances conditional cell
type selective knockouts had to be generated to circumvent
embryonic lethality of global mouse knockouts [1–3]. Adipocyte
selective inactivation of genes was possible through the identiﬁca-
tion of promoter sequences of the aP2 (fatty acid binding protein 4,
FABP4) gene [4] and the introduction of Cre/loxP technology [5]. In
recent years, these adipocyte restricted knockouts were also used
with the particular purpose to deﬁne the function of a protein in
these lipid storing cells, independent of its role in other tissues
[6–8], or to uncover the function of the protein in mature adipo-
cytes as opposed to its role during adipogenesis [9].
Two different mouse lines have been generated expressing Cre
recombinase driven by the 5.4 kb promoter/enhancer of the aP2/
FABP4 gene. The aP2-Cre mice generated by Kahn et al. were re-chemical Societies. Published by E
ntral nervous system; FABP,
y protein; b-gal, b-galactosi-
ered saline; PNS, peripheral
l Metabolism, Department of
B 3000 Leuven, Belgium. Fax:
(M. Baes).and brown adipose tissue (BAT) (70–99%) [6,8]. In the other aP2-
Cre line created by Evans et al. (available from Jackson Laboratory)
[1], Cre is also expressed in both adipose tissues, but, surprisingly,
it was recently shown that Cre is ectopically active in developing
trigeminal ganglia, dorsal root ganglia, cartilage primordia and ver-
tebrae [10]. Because the latter osteoblastic tissues were shown to
contain increased numbers of lipid droplets and since they share
a mesenchymal stem cell progenitor in common with adipocytes,
it was concluded that these cells have adipocyte-like properties
[10]. Our studies now reveal that the aP2 promoter also drives gene
inactivation in different brain regions, including the hypothalamus,
which is a central notch in regulating metabolism homeostasis
[11,12], as well as in the peripheral nervous system (PNS) which
is an essential player in the control of adipose tissue function
[13]. In our investigations, the two published aP2-Cre lines were
used, which were bred with either lacZ reporter mice [14] or with
ﬂoxed Pex5 mice [15].2. Materials and methods
2.1. Chemicals
Enzymes were purchased from Roche (Mannheim, Germany),
chemicals from Sigma–Aldrich (Bornem, Belgium), primers andlsevier B.V. All rights reserved.
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from Biosolve (Valkenswaard, the Netherlands) or Acros (Geel,
Belgium).
2.2. Mouse breeding
Two different aP2-Cre mouse lines were used. The aP2-Cre1 line
(strain B6.Cg-Tg(Fabp4-Cre) 1Rev/J) was obtained from The Jack-
son Laboratory (Bar Harbor, ME) [1] and the aP2-Cre2 line was
kindly provided by Kahn (Boston, USA) [6]. The ﬁrst Cre line was
crossed with either the LacZ-ROSA (R26R) reporter mouse (strain
B6.129S4-Gt(ROSA)26Sortm1Sor) from The Jackson Laboratory [14]
or with ﬂoxed Pex5mice (Swiss Webster) [15]. The second Cre line
was only crossed with ﬂoxed Pex5 mice [15]. Genotyping was per-
formed as previously reported [16]. Upon expression of Cre in the
LacZ reporter mouse, a ﬂoxed stop codon preceding the LacZ gene is
excised resulting in expression of b-galactosidase (b-gal). In the
aP2-Pex5 knockout mice, expression of Cre leads to excision of four
essential exons of the Pex5 gene, resulting in loss of import compe-
tent peroxisomes. All mice were 4 weeks old at the time of analy-
sis, unless otherwise indicated.
All experiments were performed in accordance with the
‘‘Guidelines for Care and Use of Experimental Animals” and fully
approved by the Research Ethical committee of the K.U. Leuven.
2.3. Histochemistry and immunohistochemistry
For X-gal staining, anaesthetized mice were perfused intracardi-
ally with 1% formaldehyde, 0.2% glutaraldehyde, 0.02% NP-40 in
phosphate buffered saline (PBS), pH 7.4. After dissection, tissues
were post-ﬁxed for 3 hours. The X-gal staining consisted of incuba-
tion at 30 C overnight in the staining solution (1 mg/ml X-gal
solution (50 lg/ml in dimethylformamide, Invitrogen, Merelbeke,
Belgium), 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2 in PBS,
pH 7.4). Whole organs were washed with PBS, reﬁxed overnight
in 4% formaldehyde and embedded in parafﬁn. 5 lm thick sections
were counterstained with Nuclear fast red (Solvent blue 38).
For immunoﬂuorescent stainings, mice were perfused with 10%
neutral buffered formalin and sectioned into 10 lm frozen sections
as previously described [17]. The following primary antibodies
were used: glial acidic ﬁbrillary protein (GFAP) (Sigma, Bornem,
Belgium) and neuronal nuclei (NeuN) (Chemicon, Temecula, USA)
raised in mice at a 1/100 dilution; catalase (Rockland, Gilbertsville,
PA) and b-galactosidase (Cappel, CA, USA) raised in rabbits at a 1/
100 and 1/400 dilution.
2.4. Northern blot analysis
Total RNA was isolated using the Trizol reagent (Invitrogen,
Merelbeke, Belgium) according to the manufacturer’s speciﬁca-
tions. Northern blot analysis was performed as previously de-
scribed [18]. The blots were hybridized with a Pex5 probe
directed to the 50 region of the transcript and quantiﬁed via Ima-
geJ. The percent recombination is determined as the ratio of
radioactivity present in the recombined Pex5 band to the total
radioactivity in wild type and recombined transcripts.3. Results
3.1. aP2-Cre1 mice cause gene recombination in the CNS and PNS,
besides adipose tissue
aP2-Cre1 mice were bred with LacZ-ROSA (R26R) reporter mice
[14] to visualize the tissues in which Cre mediated recombination
occurs. As expected, in 4-week-old mice, b-galactosidase activitywas present in WAT (Fig. 1A) and in BAT (Supplementary
Fig. 1A), while no expression could be detected in heart, skeletal
muscle, pancreas or liver nor in adipose tissue of control mice
(Supplementary Fig. 1A). X-gal staining was also observed in dorsal
root ganglia and in vertebrae as previously reported [10] but also in
celiac and superior cervical ganglia (Fig. 1B–D), in the medulla –
but not in the cortex – of the adrenals (Fig. 1E) and in the skin (Sup-
plementary Fig. 1A). Remarkably, recombination was also detected
throughout the brain including the cortex, hippocampus, hypothal-
amus (Fig. 1F, G, and I), cerebellum (Fig. 1H), spinal cord but not in
corpus callosum. In order to evaluate at which age this ectopic
recombination occurs, X-gal staining was repeated on brain and
spinal cord of 1-day-old pups. Similar as in adult mice, blue stain-
ing was observed throughout the brain and spinal cord. To assess
which cell types in the brain expressed Cre recombinase, double
immunoﬂuorescent stainings were performed of b-galactosidase
with either NeuN, which detects most neuronal cell types or with
GFAP which is used as a marker for astrocytes. This clearly demon-
strated that Cre recombinase fully colocalised with neurons but not
with astrocytes (Fig. 1G–I).
3.2. aP2-Pex5 mice loose import competent peroxisomes in ganglia
and brain besides adipose tissue
Since LacZ reporter mice do not allow to judge the functional
consequences of Cre recombination, aP2-Cre1mice were bred with
another ﬂoxed mouse line, in casu Pex5-loxP mice [15], in which a
crucial gene for import of peroxisomal matrix proteins was ﬂoxed.
Northern blot analysis was performed to determine the expression
of the wild type Pex5 transcript versus the shorter transcript de-
rived from the recombined allele. In six mice from independent lit-
ters we found that the Pex5 gene was excised by 78.3 ± 2.7% in
WAT and BAT (Fig. 2A), which is excellent given the presence of
nonadipose cells in these tissues. This was conﬁrmed by quantita-
tive RT-PCR on the wild type Pex5 transcript which was reduced to
16.3 ± 3.5% in the knockout mice. In agreement with previous re-
ports and with the LacZ data no recombination was noticed in liver,
skeletal muscle, heart and kidney (Supplementary Fig. 2A). Recom-
bination in brain was 60.1 ± 5.3% (n = 4) which is also in line with
the data of the LacZ reporter mice (Fig. 2A). In contrast to the LacZ
experiments, no shortened Pex5 transcript was found in adrenals
(combined medulla and cortex) (Fig. 2A).
To investigate Pex5 gene recombination at a cellular level, the
ability of peroxisomes to import matrix proteins was investigated
in peripheral ganglia, adrenal medulla and brain by examining the
subcellular distribution of catalase, a peroxisomal marker enzyme.
Whereas in control tissue the typical peroxisomal punctuate pat-
tern of catalase was detected, an estimated 50% of cells in the
hypothalamus and in dorsal root ganglia showed a cytosolic loca-
tion of catalase (Fig. 2B). In adrenal medulla chromafﬁn cells, only
the regular punctuate staining of catalase was observed, in agree-
ment with the northern blot data (Fig. 2B). These results demon-
strate that the aP2 promoter driving Cre expression causes
inactivation of peroxisomes in the central and peripheral nervous
system.
3.3. aP2-Cre2 mice cause variable recombination in adipose tissue
The efﬁciency and selectivity of Cre recombinase activity elic-
ited by aP2-Cre2 mice was examined by breeding with Pex5-loxP
mice and performing northern blot analysis. In gonadal and subcu-
taneous WAT recombination of the Pex5 gene were, respectively,
22.2 ± 0.4% and 48.9 ± 2.1%, whereas in BAT 47.4 ± 1.9% of Pex5
transcripts were present in the recombined band. In view of this
very low recombination efﬁciency in the tissues of interest, this
mouse line was not useful for further research and other tissues
Fig. 1. Localisation of b-galactosidase reporter gene recombination induced by aP2-Cre1 mice. To visualize b-galactosidase expression either X-gal staining (A–F) or b-
galactosidase immunohistochemistry (G–I) was used. In 4-week-old aP2-Cre1-LacZFl/Fl mice b-gal activity was present in white adipocytes (A), in neural crest derived tissues
such as dorsal root ganglia (B), celiac (C) and superior cervical ganglia (D), in the adrenal medulla (E) – but not in the cortex of this tissue – and in brain (F, coronal section). In
brain, b-galactosidase expression (green) colocalised with a neuronal marker (NeuN, red) in cortex (G) and cerebellum (H) but not with an astrocytic marker (GFAP, (I) red).
Scale bar: (A–D), 25 lm; (E), 50 lm; (F), 1000 lm; and (G–I), 20 lm.
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does not permit to study the consequences of gene ablation in a
particular tissue.
4. Discussion
Over the last decade, numerous genetic studies have relied on
the use of Cre-driver lines to draw conclusions about the role of
signaling molecules in metabolic tissues of mice. In many cases,
entirely novel concepts were deduced from such studies, haralding
innovative research avenues. However, sometimes, expression of
the Cre transgene has been more promiscuous than originally
anticipated. This is not necessarily problematic, at least as long
as such ectopic Cre expression is recognized.
The 5.4 kb promoter/enhancer of the aP2/FABP4 gene which is
generally thought to provoke adipose speciﬁc expression appears
to be prone to diverse problems of efﬁciency, consistency andselectivity. The aP2-Cre2 line, in particular, displayed variable efﬁ-
ciency of recombination in WAT and BAT as already reported [6,8].
In fact, we observed much lower efﬁciencies in all the mice that we
tested preventing to use them for functional studies of the protein
of interest. Possibly, this low Cre activity is due to the particular
breeding circumstances or genetic background.
With regard to selectivity, expression of Cre driven by the aP2/
FABP4 promoter occurs predominantly in WAT and BAT and in
bone marrow, which all contain adipocytes. However, aP2-Cre
expression was recently also reported in macrophages and endo-
thelial cells [19–22]. The efﬁciency of Cre in the latter cell types
was lower than in adipocytes based on non quantitative RT-PCR
analysis [21]. Ectopic activity of the aP2 promoter was also recog-
nized in certain progenitor cells during embryonic development by
Urs et al. [10]. In the present study, we found besides recombina-
tion in osteogenic cells and dorsal root ganglia, additional Cre
activity in other ganglia of the peripheral nervous system such as
Fig. 2. aP2-Cre1 mice drive Pex5-loxP gene recombination in adipocytes, in brain and in ganglia. (A) Northern blot on tissues of aP2-Pex5 knockout mice shows the relative
abundance of the full length wild type Pex5mRNA and the shorter transcript derived from the recombined Pex5 allel. In subcutaneous (S) and gonadal (G) WAT and in BAT the
majority of the Pex5 alleles are recombined, as expected. Notably, in different brain areas (cortex (Co), hypothalamus (H) and cerebellum (Ce)) more than 50% of transcripts
are from the recombined allele, however, no short Pex5 fragment could be detected in adrenal gland (AG). (B) Sections of the brain, of dorsal root ganglia (DRG) and of adrenals
were stained with antibodies to the peroxisomal marker enzyme, catalase showing a punctuate peroxisomal pattern in wild type mice (arrows) and a mixed cytosolic
(arrowheads) and peroxisomal pattern (arrows) in brain and DRG of aP2-Pex5 knockout mice. In adrenal medulla, a normal peroxisomal pattern was observed in the knockout
mice. Scale bars: brain, 20 lm; DRG, 10 lm, and adrenal, 10 lm.
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dulla. This particular tissue distribution strongly suggests that Cre
was expressed in trunk neural crest cells in early embryonic devel-
opment. Furthermore, strong Cre activity was noticed in the prena-
tal CNS. In a few previous studies, it was explicitly mentioned that
aP2-Cre was not active in brain [9,23], but in most other reports no
thorough evaluation of the target gene recombination in all rele-
vant tissues was performed. The activity of Cre in adrenal medulla
was contradictory between the LacZ reporter mice, showing blue
staining, and the aP2-Pex5 knockout mice, which contained normal
import competent peroxisomes. A likely explanation is that X-gal
staining already appears when a single ﬂoxed lacZ allele is recom-
bined, whereas both ﬂoxed Pex5 alleles need to be inactivated in
order to impair peroxisomal import, possibly requiring higher
Cre expression. This underscores that analysis of cell type selective
gene recombination, should preferentially be performed with the
gene of interest.
In their study [10], Urs et al. come to the conclusion that the
embryonic expression of Cre is only relevant when targeting genes
that are expressed during embryonic development. In adulthood,expression of endogenous aP2 and of aP2 driven constructs might
indeed become more adipose selective. However, because Cre
mediated recombination is irreversible, all tissues that derive from
the progenitor cells in which recombination occurred, will have
impaired function of the targeted gene.
A possible strategy to avoid the problem of embryonic expres-
sion of Cre, is to use a transgenic mouse line that expresses the
tamoxifen inducible fusion protein of Cre recombinase with a mu-
tated ligand binding domain of the human estrogen receptor under
the control of the aP2 promoter [24]. Only after treatment of the
mice with tamoxifen, Cre mediated recombination will occur. An
alternative is the use of another adipose speciﬁc promoter, such
as the adiponectin promoter [25]. Also in this case, caution is nec-
essary because new studies revealed that adiponectin is also se-
creted by other cell types, such as hepatocytes, myotubes,
skeletal muscle and osteoblasts [26].
Considering the strong endocrine interactions between adipose
tissue, liver, muscle and pancreas, it is certainly important that no
Cre mediated inactivation of the target gene occurred in these tis-
sues, as also concluded in previous reports. However, in view of the
1058 K. Martens et al. / FEBS Letters 584 (2010) 1054–1058extensive innervation and adrenergic control of bothWAT and BAT,
the widespread aP2-Cre driven recombination in the CNS and PNS
is highly relevant and urges for caution when one strives to inves-
tigate adipocyte autonomous effects of gene inactivation
[12,13,27].
In conclusion, depending on the objectives of the research, po-
tential ectopic expression should be taken into account when using
aP2-Cre mice to investigate the role of candidate regulators of adi-
pocyte function.
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